Literature DB >> 1369181

The membrane dialysis bioreactor with integrated radial-flow fixed bed--a new approach for continuous cultivation of animal cells.

A Bohmann1, R Pörtner, J Schmieding, V Kasche, H Märkl.   

Abstract

A hybridoma cell was cultivated continuously in a membrane dialysis bioreactor with an integrated radial-flow fixed bed consisting of porous Siran carriers over a period of 6 weeks. Antibodies accumulated to an average of 100 mg l-1, approx. 10 times more than in fixed bed cultures without dialysis membrane. Serum costs could be reduced about 85% due to an appropriate feeding strategy. Siran carriers with 3-5 mm diameter showed an advantage compared to those with 1-2 mm diameter. For the 3-5 mm carrier the specific glucose uptake rate and the MAb production rate were constant, if the velocity was between 0.09 mm s-1 and 0.75 mm s-1. At higher velocities cells are washed out of the bed. Furthermore antibody consistency and cell stability were verified in long-term cultivations over a period of 96 days. From an estimation of the antibody concentration reachable with the reactor concept under optimal conditions a concentration 45 times higher compared to axial-flow fixed bed reactors and 11 times higher compared to stirred tank reactors can be expected.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1369181     DOI: 10.1007/bf02521731

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  2 in total

1.  Studies on monoclonal antibody production by a hybridoma cell line (C1E3) immobilised in a fixed bed, porosphere culture system.

Authors:  A J Racher; D Looby; J B Griffiths
Journal:  J Biotechnol       Date:  1990-07       Impact factor: 3.307

2.  Monoclonal antibody production in dialyzed continuous suspension culture.

Authors:  T I Linardos; N Kalogerakis; L A Behie; L R Lamontagne
Journal:  Biotechnol Bioeng       Date:  1992-03-05       Impact factor: 4.530

  2 in total
  4 in total

1.  Dialysis cultures with immobilized hybridoma cells for effective production of monoclonal antibodies.

Authors:  R Pörtner; I Lüdemann; H Märkl
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

2.  Performance of a membrane-dialysis bioreactor with a radial-flow fixed bed for the cultivation of a hybridoma cell line.

Authors:  A Bohmann; R Pörtner; H Märkl
Journal:  Appl Microbiol Biotechnol       Date:  1995-10       Impact factor: 4.813

3.  Effect of bcl-2 expression on hybridoma cell growth in serum-supplemented, protein-free and diluted media.

Authors:  D Fassnacht; S Rössing; F Franěk; M Al-Rubeai; R Pörtner
Journal:  Cytotechnology       Date:  1998-05       Impact factor: 2.058

4.  Improvement of the culture stability of non-anchorage-dependent animal cells grown in serum-free media through immobilization.

Authors:  I Lüdemann; R Pörtner; C Schaefer; K Schick; K Srámkova; K Reher; M Neumaier; F Franěk; H Märkl
Journal:  Cytotechnology       Date:  1995-06       Impact factor: 2.058

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.